Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
[Alpha-melanocyte-stimulating hormone. From bench to bedside].
[erythropoietic protoporphyria]
Alpha
-melanocyte-stimulating
hormone
(
alpha-
MSH
)
is
a
tridecapeptide
that
is
produced
by
the
skin
itself
from
the
precursor
proopiomelanocortin
.
It
crucially
mediates
ultraviolet
light-induced
tanning
after
binding
to
melanocortin-
1
receptors
(
MC
-
1
R
)
expressed
on
the
surface
of
epidermal
melanocytes
.
The
potent
pigment-inducing
and
also
cytoprotective
actions
of
alpha-
MSH
are
the
rationale
for
the
performance
of
first
phase
II
clinical
trials
with
Nle
4
-
D-Phe
7
-
alpha-
MSH
(
NDP
-alpha-MSH
)
,
a
subcutaneously
administered
synthetic
and
superpotent
alpha-
MSH
analogue
,
in
patients
with
photodermatoses
such
as
erythropoietic
protoporphyria
.
Since
alpha-
MSH
has
shown
promising
anti-
inflammatory
and
antifibrotic
properties
in
numerous
preclinical
studies
,
it
will
be
most
interesting
to
evaluate
these
effects
in
further
clinical
pilot
studies
with
NDP
-alpha-MSH
.
In
addition
to
alpha-
MSH
analogues
,
truncated
tripeptides
such
as
KDPT
which
do
not
bind
to
MC
-
1
R
but
have
sustained
anti-
inflammatory
properties
are
currently
emerging
as
another
novel
therapeutic
strategy
in
dermatology
.
Diseases
Validation
Diseases presenting
"first phase"
symptom
erythropoietic protoporphyria
hirschsprung disease
junctional epidermolysis bullosa
kallmann syndrome
oligodontia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom